Institution · Oligomerix (United States)
Most cited papers from Oligomerix (United States)
What are the most cited papers from Oligomerix (United States)?
The most cited paper from Oligomerix (United States) is "Extracellular Tau Oligomers Produce An Immediate Impairment of LTP and Memory" (Mauro Fà et al., 2016), with 281 citations. Next come "Tau pathology in neurodegenerative disease: disease mechanisms and therapeutic avenues" (133) and "Trimeric Tau Is Toxic to Human Neuronal Cells at Low Nanomolar Concentrations" (92).
Showing 26 of 26 papers. Every paper is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Extracellular Tau Oligomers Produce An Immediate Impairment of LTP and Memory Mauro Fà et al. · Scientific Reports | 20 Jan 2016 | 281 |
| 2 | Tau pathology in neurodegenerative disease: disease mechanisms and therapeutic avenues Niyatee P. Samudra, Courtney Lane‐Donovan, Lawren A. VandeVrede et al. · Journal of Clinical Investigation | 14 Jun 2023 | 133 |
| 3 | Trimeric Tau Is Toxic to Human Neuronal Cells at Low Nanomolar Concentrations Huilai Tian, Eliot J. Davidowitz, Patrícia Luciana da Costa Lopez et al. · International Journal of Cell Biology | 2013 | 92 |
| 4 | Isolation and characterization of antibody fragments selective for toxic oligomeric tau Huilai Tian, Eliot J. Davidowitz, Patricia Luciana da Costa Lopez et al. · Neurobiology of Aging | 11 Dec 2014 | 27 |
| 5 | In Vivo Validation of a Small Molecule Inhibitor of Tau Self-Association in htau Mice Eliot J. Davidowitz, Pavan Krishnamurthy, Patricia Luciana da Costa Lopez et al. · Journal of Alzheimer s Disease | 19 Nov 2019 | 17 |
| 6 | Small molecule inhibitor of tau self-association in a mouse model of tauopathy: A preventive study in P301L tau JNPL3 mice Eliot J. Davidowitz, Patrícia Luciana da Costa Lopez, Heidy T. Jimenez et al. · PLoS ONE | 9 Aug 2023 | 14 |
| 7 | Therapeutic Treatment With OLX ‐07010 Inhibited Tau Aggregation and Ameliorated Motor Deficits in an Aged Mouse Model of Tauopathy Eliot J. Davidowitz, Pedro F. Lopez, Dilip R. Patel et al. · Journal of Neurochemistry | Mar 2025 | 6 |
| 8 | P1‐361: Extracellular oligomeric tau inhibits memory formation in mice James G. Moe, Ishita Chatterjee, Daniela Puzzo et al. · Alzheimer s & Dementia | Jul 2010 | 5 |
| 9 | P4‐236: Modulation of synaptic function by extracellular tau enriched in oligomers James G. Moe, Ishita Chatterjee, Eliot J. Davidowitz et al. · Alzheimer s & Dementia | 25 Jun 2009 | 5 |
| 10 | P1‐084: Small Molecule TAU Oligomerization Inhibitors James G. Moe, Pavan Krishnamurthy, Patrícia Luciana da Costa Lopez et al. · Alzheimer s & Dementia | Jul 2016 | 3 |
| 11 | [P4–589]: CNS DRUG‐LIKE INHIBITORS OF TAU OLIGOMERIZATION James G. Moe, Charles Gluchowski, Pavan Krishnamurthy et al. · Alzheimer s & Dementia | Jul 2017 | 2 |
| 12 | P4‐212: DRUG DEVELOPMENT OF INHIBITORS OF TAU OLIGOMER FORMATION FOR ALZHEIMER'S DISEASE AND TAUOPATHIES James G. Moe, Pavan Krishnamurthy, Patrícia Luciana da Costa Lopez et al. · Alzheimer s & Dementia | Jul 2014 | 2 |
| 13 | P3‐161: Tau autoproteolytic activity is induced by tau oligomerization Eliot J. Davidowitz, James G. Moe · Alzheimer s & Dementia | Jul 2011 | 2 |
| 14 | P4–423: Small‐molecule lead identification for inhibition of tau oligomer formation James G. Moe, James A. Hendrix, Patrícia Luciana da Costa Lopez et al. · Alzheimer s & Dementia | Jul 2013 | 2 |
| 15 | Acute treatment with OLX‐07010 reduced tau aggregates and upregulated a marker of autophagy with dose dependence in aged P301L tau JNPL3 mice Dhruv R. Patel, Patrícia Luciana da Costa Lopez, Daisy C. Romero et al. · Alzheimer s & Dementia | Dec 2024 | 1 |
| 16 | Preclinical development of a small molecule inhibitor of tau self‐association for Alzheimer’s disease and related dementias James G. Moe, Edward H. Cheesman, Dhruv R. Patel et al. · Alzheimer s & Dementia | Dec 2022 | 1 |
| 17 | P4‐222: IN VIVO EFFICACY OF A SMALL MOLECULE INHIBITOR OF TAU OLIGOMER FORMATION IN HTAU MICE James G. Moe, Patricia Luciana da Costa Lopez, Heidy T. Jimenez et al. · Alzheimer s & Dementia | Jul 2018 | 1 |
| 18 | P3‐329: Identification of tau oligomer proteolytic activity as a novel target for drug discovery James G. Moe, Giulia Papiani, Patricia Luciana da Costa Lopez et al. · Alzheimer s & Dementia | Jul 2015 | 1 |
| 19 | Identification of pharmacodynamics readouts through acute dosing of a small molecule inhibitor of tau self‐association in a tauopathy mouse model Dhruv R. Patel, Chaya Sussman, Mindy Greco et al. · Alzheimer s & Dementia | Dec 2021 | 0 |
| 20 | In vivo validation of therapeutic efficacy of a small molecule lead targeting tau self‐association in JNPL3 mice James G. Moe, Patricia Luciana da Costa Lopez, Heidy T. Jimenez et al. · Alzheimer s & Dementia | Dec 2021 | 0 |
| 21 | In vivo validation of a lead compound targeting tau self‐association in two mouse models of tauopathy James G. Moe, Patricia Luciana da Costa Lopez, Heidy T. Jimenez et al. · Alzheimer s & Dementia | Dec 2020 | 0 |
| 22 | P4‐698: LINEAR DOSE‐DEPENDENT INHIBITION OF TAU AGGREGATION IN VIVO WITH SMALL MOLECULE James G. Moe, Patricia Luciana da Costa Lopez, Heidy T. Jimenez et al. · Alzheimer s & Dementia | Jul 2019 | 0 |
| 23 | P4‐319: Characterization of tool compounds targeting tau oligomers Pavan Krishnamurthy, Daisy C. Romero, Patricia Luciana da Costa Lopez et al. · Alzheimer s & Dementia | Jul 2015 | 0 |
| 24 | P3‐007: Development of tau proteolytic activity as a target for drug discovery James G. Moe, Eliot J. Davidowitz, Patricia Luciana da Costa Lopez · Alzheimer s & Dementia | Jul 2012 | 0 |
| 25 | P1–212: Detection of soluble oligomeric tau with morphology‐specific antibody fragments as a potential diagnostic method for Alzheimer's disease Huilai Tian, Eliot J. Davidowitz, James G. Moe et al. · Alzheimer s & Dementia | Jul 2013 | 0 |
| 26 | P1–411: Characterization of a novel monoclonal antibody specific for a tau autoproteolytic cut site that differentiates between Alzheimer's disease and non‐Alzheimer's specimens Eliot J. Davidowitz, Patricia Luciana da Costa Lopez, James G. Moe · Alzheimer s & Dementia | Jul 2013 | 0 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.